Cargando…

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy

PURPOSE: To investigate the relationships between Wnt1 inducible signaling pathway protein 1 (WISP1) polymorphisms and the prognosis of platinum-based chemotherapy in lung cancer patients. PATIENTS AND METHODS: A total of 363 lung cancer patients were recruited in this study. All of them received at...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jia, Wang, Zhan, Wang, Ying, Zou, Ting, Li, Xiang-Ping, Cao, Lei, Chen, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458023/ https://www.ncbi.nlm.nih.gov/pubmed/34566424 http://dx.doi.org/10.2147/PGPM.S325788

Ejemplares similares

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
por: Chen, Juan, et al.
Publicado: (2014)

The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
por: He, Jia, et al.
Publicado: (2022)

The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2022)

Association of variations in platinum resistance-related genes and prognosis in lung cancer patients
por: Zhou, Yuan-Kang, et al.
Publicado: (2020)

The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Zou, Ting, et al.
Publicado: (2020)

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
por: Liu, Jia-Si, et al.
Publicado: (2023)

Genetic Variants in DNA Mismatch Repair Pathway predict prognosis of Lung Cancer patients with receiving Platinum-Based Chemotherapy
por: Liu, Jun-Yan, et al.
Publicado: (2020)

Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
por: Chen, Yi-Xin, et al.
Publicado: (2021)

WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis
por: Lu, Yongliang, et al.
Publicado: (2016)

Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer
por: Chen, Ping-Ping, et al.
Publicado: (2007)

Astrophysics Ethereal wisps
Publicado: (2009)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
por: Afifah, Nadiya Nurul, et al.
Publicado: (2020)

Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancer
por: Wang, Lei-Yun, et al.
Publicado: (2018)

Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis
por: Chen, Juan, et al.
Publicado: (2016)

High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis
por: Wu, Jianghong, et al.
Publicado: (2016)

Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis
por: Liu, Wenhui, et al.
Publicado: (2020)

Dysfunction of Collagen Synthesis and Secretion in Chondrocytes Induced by Wisp3 Mutation
por: Wang, Min, et al.
Publicado: (2013)

Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients
por: Li, Yue-Qin, et al.
Publicado: (2018)

Search for WISPs gains momentum
por: Lindner, Axel, et al.
Publicado: (2018)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Yi, Yonglin, et al.
Publicado: (2022)

WISP1 and TLR4 on Macrophages Contribute to Ventilator-Induced Lung Injury
por: Yu, Zhuang, et al.
Publicado: (2020)

Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2018)

Dual effect of WISP-1 in diverse pathological processes
por: Feng, Mengmeng, et al.
Publicado: (2016)

An Intuitionistic Extension of the Simple WISP Method
por: Zavadskas, Edmundas Kazimieras, et al.
Publicado: (2022)

Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
por: Zhu, Kaibo, et al.
Publicado: (2021)

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
por: Zhang, Jian, et al.
Publicado: (2015)

Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients
por: Wu, Wenting, et al.
Publicado: (2012)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer
por: Song, Xiao, et al.
Publicado: (2017)

A miR‐15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum‐based chemotherapy
por: Xue, Ping, et al.
Publicado: (2022)

The emerging role of WISP proteins in tumorigenesis and cancer therapy
por: Liu, Yi, et al.
Publicado: (2019)

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
por: Zhai, Xiaoyu, et al.
Publicado: (2017)

Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis
por: Cao, Ailing, et al.
Publicado: (2019)

CCN5/WISP2 and metabolic diseases
por: Grünberg, John R, et al.
Publicado: (2017)

WISP3 mutation associated with pseudorheumatoid dysplasia
por: Sailani, M. Reza, et al.
Publicado: (2018)

The Association of Transporter Genes Polymorphisms and Lung Cancer Chemotherapy Response
por: Wang, Ying, et al.
Publicado: (2014)

WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
por: Liao, Xia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dja615iscj70jgda9n3nrc5ia6